Patricia Hurley, PhD has a vast experience in regulatory affairs, having worked in various capacities in companies such as invoX Pharma Limited, F-star Therapeutics Ltd, and PPD. Patricia has also held positions in project management and biomarkers division at ERA Consulting. With a background in pharmacology and molecular genetics, Patricia has contributed significantly to the development of innovative therapeutics and diagnostic biomarkers. Patricia is currently serving as the VP of Regulatory Affairs at invoX Pharma Limited and is an Editorial Board Member of Regulatory Rapporteur at TOPRA.
June, 2023 - present